ERT Expands Suite of eCOA Offerings to Include Bring Your Own Device (BYOD) Solution - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
ERT Expands Suite of eCOA Offerings to Include Bring Your Own Device (BYOD) Solution

Source: Company News Release

ERT, a leading global solution provider for high-quality patient safety and efficacy endpoint data collection, today announced an expansion to its comprehensive suite of electronic Clinical Outcome Assessment (eCOA) data collection solutions for use in clinical trials.  With this expansion, clinical trial sponsors can improve trial efficiencies while reliably collecting important eCOA data via patients’ personal Apple® (iOS) or Android™ phones and tablets.

An extension of ERT’s flagship DIARYpro® solution, the Bring Your Own Device (BYOD) option is based on over 25 years of scientifically and regulatory-proven COA data collection experience.  This native mobile application enables trial sponsors to acquire high-quality eCOA data while eliminating the cost and time associated with purchasing, shipping, and managing a global fleet of dedicated eCOA devices.  In addition, ERT’s BYOD solution ensures that assessments are presented consistently across different device types and screen resolutions.

“DIARYpro has set the industry standard for high data quality and reliability,” said Bob Young, EVP and Product Line Executive, eCOA at ERT.  “In expanding the solution to include a BYOD option, we conducted significant research among global clinical trial sponsors to ensure it not only meets these standards, but also offers valuable features that will streamline the eCOA data collection process.”

Unlike other mobile applications that run within web browsers and require a live internet connection, ERT’s BYOD solution allows fully-offline operation for when data must be entered during strict time windows, regardless of internet connectivity. Further, on-device reminders to begin or continue assessments are not dependent on any external email or text server, and these notifications blend naturally into smartphone users’ daily lives, enhancing compliance.

Having supported over 1,200 COA global clinical trials to date, ERT’s solutions and services are routinely relied upon by biopharmaceutical researchers for capturing important patient data during clinical development.  For more information on ERT’s comprehensive suite of eCOA data collection solutions, including BYOD, visit www.ert.com/eCOA.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here